RxDoctor Payments Data

Jessica Poisson, MD

Anatomic Pathology & Clinical Pathology · Durham, NCNPI 1518128511

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (40.2%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. Cerus Corporation accounts for 60.3% of it on its own, with 2 other manufacturers making up the rest. Among anatomic pathology & clinical pathology clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,961in general payments, 2019–2025

Across 9 payments — averaging $551.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cerus Corporation$3K
  • Gilead$2K
  • AbbVie$49
$163,038in research payments, 2019–2025

Across 5 payments — averaging $32,608 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Cerus Corporation$163K

What the payments were for

  • Consulting fees$1,79036%
  • Speaking & faculty fees$1,00020%
  • Travel & lodging$1,99240%
  • Food & beverage$1794%

General payments by program year

19
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Cerus Corporation4$2,992
Gilead3$1,920
AbbVie2$49

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,961 in reported general payments places this provider in the 90th percentile of 221 anatomic pathology & clinical pathology providers in North Carolina.

See all anatomic pathology & clinical pathology providers in North Carolina

Medicare billing

Part B allowed, 2024
$5,031
Medicare patients
102
Services billed
113

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Durham

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →